Predictors of Recurrence for High Risk Endometrial Cancer Patients
Completed
- Conditions
- High-risk Endometrial Cancer
- Registration Number
- NCT04412902
- Lead Sponsor
- Far Eastern Memorial Hospital
- Brief Summary
This study will analyze whether there is any difference in recurrence and survival rates among the patients who received different adjuvant therapies.
- Detailed Description
The incidence of endometrial cancer is gradually increasing nowaday. The postoperative treatment of high-risk endometrial cancer is also inconsistent. Besides, the recurrence of high-risk endometrial cancer is high.The investigators retrospective study will analyze the factors associated with recurrence of endometrial cancer, especially for different adjuvant therapies.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 92
Inclusion Criteria
- All patients with high risk stage I endometrial cancer and all patients with stage II and stage III endometrial cancer and who underwent therapy in Far Eastern Memorial Hospital from 2009/01/01~2019/09/17.
Exclusion Criteria
- Patients with stage I endometrial cancer do not have high risk factors.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Factors affecting overall survival 10 years Factors affecting overall survival
- Secondary Outcome Measures
Name Time Method Factors affecting progression-free survival 10 years Factors affecting progression-free survival
Trial Locations
- Locations (1)
Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital
🇨🇳Banqiao, New Taipei, Taiwan